About PTCA balloon catheter
PTCA is a minimally invasive procedure used to remove the blockage of coronary arteries, permitting uninterrupted blood flow to the heart muscle. The procedure involves the placement of a PTCA balloon catheter to compress and clear the blockage caused by plaques and to widen the clogged coronary artery. A PTCA balloon catheter is a soft device equipped with a small inflatable balloon at its tip, which is inserted into an artery during the catheterization procedure. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheter was the first of its kind used in the field of interventional cardiology. It is also used to position stents during angioplasty.
Technavio's analysts forecast the PTCA balloon catheter market in China to grow at a CAGR of 14.75% over the period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the PTCA balloon catheter market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of PTCA balloon catheters.
Technavio's report, PTCA Balloon Catheter Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• Boston Scientific
• Medtronic
• MicroPort Scientific
• Terumo
Other prominent vendors
• Aachen Resonance
• Acrostak
• AngioScore
• Alvimedica
• Asahi Intecc
• Arthesys
• Atrium Medical
• B. Braun Melsungen
• Biosensors International
• BIOTRONIK
• Cordis
• Cook Medical
• C.R. Bard
• Goodman
• Lepu Medical
• Natec Medical
• Smiths Medical
• Tokai Medical Products
• Volcano
Market driver
• Growing geriatric population
• For a full, detailed list, view our report
Market challenge
• Alternative therapies
• For a full, detailed list, view our report
Market trend
• High demand for minimally invasive procedures
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. PTCA: An Overview
06.1 About PTCA
06.1.1 Background
06.1.2 Definition
06.1.3 Steps Involved in PTCA
06.1.4 Advantages of PTCA
06.1.5 Complications and Risks Involved in PTCA
06.1.6 PTCA Balloon Catheters Affected Individuals
06.2 PTCA Balloon Catheter Materials
06.2.1 Comparison of Catheter Materials
06.3 Complications of Catheterization
06.3.1 Background
06.3.2 Causes of Complications
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Product Type
08.1 Normal Balloon Catheter
08.2 Drug-Eluting Balloon Catheter
08.3 Cutting Balloon Catheter
08.4 Scoring Balloon Catheter
09. Healthcare Reform in China
09.1 Healthcare Reforms
09.1.1 Insurance Coverage for Healthcare Access
09.1.2 Improvement in Healthcare Infrastructure
10. Opportunities for Global and Local Vendors
10.1 Local Vendors
10.1.1 Challenges for Local Vendors
10.2 Global Vendors
10.2.1 Challenges for Global Vendors
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and Their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and Their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 Abbott Laboratories
18.2.2 Boston Scientific
18.2.3 Medtronic
18.2.4 MicroPort Scientific
18.2.5 Terumo
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Boston Scientific
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Key Products
19.2.4 Key Products in Cardiovascular Segment
19.2.5 Key Products in MedSurg Segment
19.2.6 Key Products in Rhythm Management Segment
19.2.7 Business Segmentation by Revenue 2013
19.2.8 Business Segmentation by Revenue 2012 and 2013
19.2.9 Geographical Segmentation by Revenue 2013
19.2.10 Business Strategy
19.2.11 Recent Developments
19.2.12 SWOT Analysis
19.3 Medtronic
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Key Products
19.3.4 Business Segmentation by Revenue 2014
19.3.5 Cardiac and Vascular Group Segmentation by Revenue 2014
19.3.6 Restorative Therapies Group Segmentation by Revenue 2014
19.3.7 Diabetes Group Segmentation by Revenue 2014
19.3.8 Business Segmentation by Revenue 2013 and 2014
19.3.9 Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
19.3.10 Restorative Therapies Group Segmentation by Revenue 2013 and 2014
19.3.11 Diabetes Group Segmentation by Revenue 2013 and 2014
19.3.12 Geographical Segmentation by Revenue 2014
19.3.13 Business Strategy
19.3.14 Key Developments
19.3.15 SWOT Analysis
19.4 MicroPort Scientific
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Geographical Segmentation by Revenue 2013
19.4.6 Business Strategy
19.4.7 Recent Developments
19.4.8 SWOT Analysis
19.5 Terumo
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation
19.5.4 Revenue Segmentation by Business
19.5.5 Business Segment Revenue Comparison - FY2011 and FY2012
19.5.6 Revenue Segmentation by Geography
19.5.7 Business Strategy
19.5.8 Key Developments
19.5.9 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Various Steps of PTCA
Exhibit 3: PTCA Balloon Catheter Materials
Exhibit 4: Common HAIs in Acute Care Settings
Exhibit 5: Major PTCA Balloon Catheter Complications
Exhibit 2: PTCA Balloon Catheter Market in China 2014-2019 ($ millions)
Exhibit 6: Segmentation of PTCA Balloon Catheter Market in China by Product Type
Exhibit 7: Segmentation of PTCA Balloon Catheter Market in China by Product Type 2014
Exhibit 8: Disease Mortality in China 2012
Exhibit 9: Healthcare Reforms in China
Exhibit 10: Number of Medical Institutes in China until 2012
Exhibit 11: Various Establishments of Top Global Medical Device Companies in China
Exhibit 12: Elderly Population in China 1950-2050
Exhibit 13: Healthcare Expenditure in China 2005-2014
Exhibit 14: Abbott Laboratories: Key Takeaways
Exhibit 15: Boston Scientific: Key Takeaways
Exhibit 16: Medtronic: Key Takeaways
Exhibit 17: MicroPort Scientific: Key Takeaways
Exhibit 18: Terumo: Key Takeaways
Exhibit 19: Abbott Laboratories: Business Segmentation
Exhibit 20: Abbott Laboratories: Revenue by Business Segmentation 2012
Exhibit 21: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 ($ millions)
Exhibit 22: Abbott Laboratories: Revenue by Geographical Segmentation 2012
Exhibit 23: Boston Scientific: Key Products in Cardiovascular Segment
Exhibit 24: Boston Scientific: Key Products in MedSurg Segment
Exhibit 25: Boston Scientific: Key Products in Rhythm Management Segment
Exhibit 26: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 27: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 28: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 29: Medtronic: Key Products
Exhibit 30: Medtronic: Business Segmentation by Revenue 2014
Exhibit 31: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
Exhibit 32: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
Exhibit 33: Medtronic: Diabetes Group Segmentation by Revenue 2014
Exhibit 34: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 35: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 36: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 37: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 38: Medtronic: Geographical Segmentation by Revenue 2014
Exhibit 39: MicroPort Scientific: Business Segmentation by Revenue 2013
Exhibit 40: MicroPort Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 41: MicroPort Scientific: Geographical Segmentation by Revenue 2013
Exhibit 42: Business Segmentation of Terumo
Exhibit 43: Revenue Segmentation of Terumo
Exhibit 44: Revenue Comparison of Business Segments ($ billions)
Exhibit 45: Revenue Segmentation by Geography FY2012
